The Lessons from the COVID-19 Management of Maharat Nakhon Ratchasima Hospital for the Preparedness on Emerging and Re-emerging Infectious Disease Management

Authors

  • Prawin Tanthaprabha Maharat Nakhon Ratchasima Hospital

Keywords:

COVID-19, emerging disease, infectious disease

Abstract

Background: COVID-19 is an emerging infectious disease that spreads all over the world. In Thailand, there were many waves of the pandemic. The purpose of this research study was to obtain the lessons from the COVID-19 management for the preparedness on emerging and re-emerging infectious disease management.

Methodology: This research study is a participatory action research study. The research period was from 31st December 2019 – 31st December 2022. The qualitative and quantitative data were studied in order to obtain the lessons from Maharat Nakhon Ratchasima Hospital’s emergency operations conference (EOC) for handling COVID-19 regarding infections.

Results: In the 3rd, 4th, 5th phase, there are more patients and sick personnel. Vaccination was increased in phases 2nd and 3rd, with management changing for each phase of the study. In each pandemic phase, the number of the patients was increased. The number was significantly increased in the 2nd wave. The number of the inpatients who were treated similarly to the outpatients was increased. In the post-pandemic phase, the number of the patients was decreased. However, the number of the outpatients was still high. Regarding the COVID-19 infections, there were the patients with COVID pneumonia. The percentages of the patients with acute respiratory failures in the 3 – 5 waves in the post-pandemic phase were 11.7 - 37.8 because the inpatients had COVID pneumonia or co-morbid conditions. By opening the field hospitals, the highest numbers of the patients were in the 4th and 5th waves. MIS-C/MIS-A was found in 10 patients in the 5th stage. It was the inflammation in many systems in their bodies. It was a serious complication after the COVID-19 infections. It was life-threatening. The highest percentages of the deaths were 6.8 – 15.3 in the 4th and 5th waves in the post-pandemic stage. The highest percentage was in the post-pandemic because the symptoms of the patients were worsened. The Delta variant had the infection rate higher than that of the Alpha variant. The COVID-19 vaccination services started in the 3rd wave. The number of the vaccinated people and vaccinations were increased. It started from the 608 group, medical workers, people and young people who were younger than 18 years. AEFI was related to the number of serviced doses. The number of the sick workers increased in the 3rd wave. Most of the infections were not from the workplaces. To work in the COVID-19 situations and apply the principles of preventive medicine, there were measures such as public health measures, social measures, organizational measures, personal measures, cooperative communication measures and vaccination measures.

 Conclusion: The lessons were obtained for the emerging and re-emerging infectious disease management. It is suggested to have the followings: epidemic preparedness and rapid responses, public health infrastructures, risk communications, political commitments and partnership building, as well as research and its utilizations. 

References

Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 2020;96:753–8.

McArthur DB. Emerging infectious diseases. Nurs Clin North Am 2019;54(2):297–311.

Hemmer CJ, Löbermann M, Reisinger EC. COVID-19: epidemiology and mutations : an update. Radiologe 2021;61(10):880–7.

Long B, Carius BM, Chavez S, Liang SY, Brady WJ, Koyfman A, et al. Clinical update on COVID-19 for the emergency clinician: presentation and evaluation. Am J Emerg Med 2022;54:46–57.

Medley GF, Vassall A. When an emerging disease becomes endemic. Science 2017;357(6347):156–8.

Jiang S, Hotez PJ. Combating the emerging viral infectious diseases. Microbes Infect 2015;17(2):83.

วิรงรอง แก้วสมบูรณ์, สุธิดา วรโชติธนัน, รุจิรา หมื่นทอง, กษมา นับถือดี, คัดคนางค์ ศรีพัฒนะพิพัฒน์, เขมพรรษ บุญโญ, และคณะ. การจัดทำแผนยุทธศาสตร์เตรียมความพร้อมป้องกันและแก้ไขปัญหา โรคติดต่ออุบัติใหม่แห่งชาติ (พ.ศ. 2560-2564). วารสารควบคุมโรค 2561;44(1):50–62.

Corrado AM, Benjamin-Thomas TE, McGrath C, Hand C, Rudman DL. Participatory action research with older adults: a critical interpretive synthesis. Gerontologist 2020;60(5):e413–27.

สุรเกียรติ อาชานุภาพ. ทฤษฎีแนวคิดว่าด้วยการวิจัยระบบสาธารณสุข. วารสารวิจัยระบบสาธารณสุข 2536;1(1):7-13.

ทวีเกียรติ บุญยไพศาลเจริญ, รวินันท์ ศิริกนกวิไล. การวิจัยระบบสาธารณสุข: บทเรียนจากอยุธยา. วารสารวิจัยระบบสาธารณสุข 2536;1(1):38-51.

Di Mitri C, Arcoleo G, Mazzuca E, Camarda G, Farinella EM, Soresi M, et al. COVID-19 and non-COVID-19 pneumonia: a comparison. Ann Med 2021;53(1):2321–31.

Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021;325(11):1074–87.

Zhao Y, Yin L, Patel J, Tang L, Huang Y. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis. J Med Virol. 2021 Jul;93:4358–69.

Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev 2021;38:51–7.

UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England [Internet]. 2022 [cited 2023 Feb 3]. Available from: https://www.gov.uk/government/publications/investigation-of-sars-cov-2-variants-technical-briefings

Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet 2022;399(10335):1618–24.

Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ 2021;373:n1088.

Wikipedia. Long COVID [Internet]. 2023 [cited 2023 Feb 3]. Available from: https://en.wikipedia.org/wiki/ Long_COVID

World Health Organization. Combating emerging infectious diseases in the South-East Asia region [Internet]. 2005 [cited 2023 Feb 3]. Available from: https://apps.who.int/iris/bitstream/handle/10665/204878/B0005.pdf? sequence=1&isAllowed=y

กรมควบคุมโรค กระทรวงสาธารณสุข. แผนยุทธศาสตร์เตรียมความพร้อม ป้องกันและแก้ไขปัญหาโรคอุบัติใหม่แห่งชาติ พ.ศ. 2560-2564. นนทบุรี: กรมควบคุมโรค กระทรวงสาธารณสุข; 2559.

Downloads

Published

2023-04-30

How to Cite

1.
Tanthaprabha P. The Lessons from the COVID-19 Management of Maharat Nakhon Ratchasima Hospital for the Preparedness on Emerging and Re-emerging Infectious Disease Management. JPMAT [Internet]. 2023 Apr. 30 [cited 2024 Nov. 23];13(1):1-13. Available from: https://he01.tci-thaijo.org/index.php/JPMAT/article/view/261929

Issue

Section

Original Article